NeurAxis Q3 Sales Jump 150% to $2.0M, But Going Concern Warning Persists
NRXS has more than doubled off its 52-week low of $2.21.
Summary
NeurAxis grew Q3 revenue 150% to $2.0M with 86.6% gross margin, but a $4.3M one-time stock comp charge pushed the net loss to $6.5M and management reiterated substantial doubt about its ability to continue as a going concern.
Key Events · Earnings and Guidance · NRXS
-
Q3 Revenue More Than Doubles
Net sales rose 149.9% to $2,027,904 from $811,414 a year earlier, driven by the IB-Stim Category I CPT code effective January 1, 2026 and broader payor coverage; average selling price rose to $1,045 from $775.
-
One-Time Stock Comp Drives Loss
Net loss widened to $6,545,442 from $2,122,796, including $4,298,903 of one-time non-recurring stock compensation from exchanging 1,305,630 cancelled options for immediately vested RSUs.
-
Going Concern Doubt Reaffirmed
Management states substantial doubt exists about the company's ability to continue as a going concern, with $4,476,617 of cash against $4,527,644 of nine-month operating cash burn.
-
Material Weaknesses Persist
Disclosure controls were concluded not effective as of September 30, 2026, with previously disclosed material weaknesses in approval processes, contract management and U.S. GAAP application still unremediated.
Analysis · NRXS · Industrial Applications And Services
Revenue is inflecting: Q3 net sales of $2,027,904 more than doubled year over year on broader insurance coverage from the IB-Stim Category I CPT code effective January 1, 2026, and gross margin rose to 86.6%. The bottom line, however, deteriorated sharply — the quarterly net loss widened to $6,545,442 from $2,122,796 — because of $4,298,903 in one-time non-cash stock compensation tied to exchanging cancelled options for immediately vested RSUs. Strip that out and the operating loss still grew on higher selling, R&D and market-access spend. The bigger issue is the balance sheet: management states substantial doubt exists about the company's ability to continue as a going concern, with $4,476,617 of cash against $4,527,644 of cash burned in nine months. That cash covers roughly a year of operations only if losses don't widen, and the company says it intends to fund itself through additional dilutive financing. Material weaknesses in internal controls also remain unremediated.
How filings like this one have moved
In the 30 days to Nov 9, 2026, 47.1% of the 1533 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, NRXS was trading at $6.24 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $78.4M. The 52-week trading range was $2.21 to $9.33. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.